Experimental Treatment Increases Skin Cancer Survival Rate by 25%

New Molecular Target Could Result in Cancer Drugs With Fewer Side Effects

MIT Develops Nanoparticles That Cross the Blood-Brain Barrier To Treat Cancer Tumors

A potentially more effective treatment for HER2 mutant metastatic breast cancer